Eccrine sweat disorder, unspecified
ICD-10 L74.9 is a billable code used to indicate a diagnosis of eccrine sweat disorder, unspecified.
Eccrine sweat disorder, unspecified, refers to a group of conditions affecting the eccrine sweat glands, which are responsible for thermoregulation and maintaining body temperature through sweat production. The clinical presentation can vary widely, including symptoms such as excessive sweating (hyperhidrosis), insufficient sweating (anhidrosis), or abnormal sweat production. The eccrine glands are distributed throughout the skin, particularly on the palms, soles, and forehead. Disease progression may involve episodic or chronic symptoms, impacting the patient's quality of life and leading to complications such as skin infections or heat-related illnesses. Diagnostic considerations include a thorough patient history, physical examination, and potentially sweat tests to assess gland function. Differential diagnoses may include other dermatological conditions, endocrine disorders, or neurological issues that affect sweat production. Accurate diagnosis is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L74.9 encompasses unspecified eccrine sweat disorders, which may include hyperhidrosis, anhidrosis, or other eccrine gland dysfunctions without a specific diagnosis. It is used when the exact nature of the disorder is not clearly defined.
L74.9 should be used when the clinician has not specified the type of eccrine sweat disorder, or when the condition does not fit the criteria for more specific codes such as L74.0 or L74.1.
Documentation should include a detailed patient history, clinical findings, and any diagnostic tests performed. Notes should clearly indicate the symptoms, duration, and impact on the patient's daily life.
